Medicine
Oncology

Prostate cancer
Follow-up, Quality of life


Home > Disciplines > Medicine > Oncology > Prostate cancer > Follow up


CONTENTS



OVERVIEW
RECOMMENDATIONS

ANDROGEN DEPRIVATION THERAPY

MONITORING VERSUS RADICAL PROSTATECTOMY

CARDIOVASCULAR EVENTS

CNS EVENTS

DEPRESSION

FUNCTIONAL OUTCOMES
ERECTILE DYSFUNCTION
Sildenafil
EARLY VS DELAYED USE OF SILDENAFIL
USE OF PDE-5 INHIBITORS AND BIOCHEMICAL RECURRENCE
NOCTURIA
ORGASMIC DYSFUNCTION
REDUCED PENILE SIZE
SEXUAL LIFE
URINARY INCONTINENCE

MEASUREMENT OF METASTASIS IN THE FOLLOW-UP

OSTEOPOROSIS AND FRACTURE RISK

QUALITY OF LIFE

SIDE EFFECTS OF RADIOTHERAPY
SECONDARY CANCER
BLADDER CANCER

THERANOSTICS

TREATMENT OF BENIGN ENLARGEMENT OF THE PROSTATE

SYMPTOM BURDEN





OVERVIEW


.

Adam S, Feller A, Rohrmann S, Arndt V.
Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Health Qual Life Outcomes. 2018 Jan 23;16(1):22. doi: 10.1186/s12955-017-0836-0.
Source | Full text | Similar articles



.

Albaugh JA, Sufrin N, Lapin BR, Petkewicz J, Tenfelde S.
Life after prostate cancer treatment: a mixed methods study of the experiences of men with sexual dysfunction and their partners.
BMC Urol. 2017 Jun 15;17(1):45. doi: 10.1186/s12894-017-0231-5.
Source | Full text | Similar articles



.

Dahm P, Wilt T.
In prostate cancer, urinary and sexual function were worse with prostatectomy than active monitoring or radiotherapy.
Ann Intern Med. 2016 Dec 20;165(12):JC62. doi: 10.7326/ACPJC-2016-165-12-062.
Source | Full text | Similar articles



.

Spratt DE.
To ProtecT Our Patients With Prostate Cancer.
JAMA Oncol. 2017 Mar 16. doi: 10.1001/jamaoncol.2017.0274. [Epub ahead of print]
Source | Full text | Similar articles



.

Venderbos LD, Aluwini S, Roobol MJ, Bokhorst LP, Oomens EH, Bangma CH, Korfage IJ.
Long-term follow-up after active surveillance or curative treatment: quality-of-life outcomes of men with low-risk prostate cancer.
Qual Life Res. 2017 Feb 6. doi: 10.1007/s11136-017-1507-7. [Epub ahead of print]
Source | Full text | Similar articles



.

Tsikis ST, Nottingham CU, Faris SF.
The Relationship Between Incontinence and Erectile Dysfunction After Robotic Prostatectomy: Are They Mutually Exclusive?
J Sex Med. 2017 Sep 2. pii: S1743-6095(17)31353-X. doi: 10.1016/j.jsxm.2017.08.002. [Epub ahead of print]
Source | Full text | Similar articles

PATIENT-REPORTED OUTCOMES


.

Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, Conwill R, McCollum D, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Penson DF.
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
JAMA. 2017 Mar 21;317(11):1126-1140. doi: 10.1001/jama.2017.1704.
Source | Full text | Similar articles



.

Chen RC, Basak R, Meyer AM, Kuo TM, Carpenter WR, Agans RP, Broughman JR, Reeve BB, Nielsen ME, Usinger DS, Spearman KC, Walden S, Kaleel D, Anderson M, Stürmer T, Godley PA.
Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
JAMA. 2017 Mar 21;317(11):1141-1150. doi: 10.1001/jama.2017.1652.
Source | Full text | Similar articles



.

Donovan JL, Hamdy FC, Lane JA, Mason M, Metcalfe C, Walsh E, Blazeby JM, Peters TJ, Holding P, Bonnington S, Lennon T, Bradshaw L, Cooper D, Herbert P, Howson J, Jones A, Lyons N, Salter E, Thompson P, Tidball S, Blaikie J, Gray C, Bollina P, Catto J, Doble A, Doherty A, Gillatt D, Kockelbergh R, Kynaston H, Paul A, Powell P, Prescott S, Rosario DJ, Rowe E, Davis M, Turner EL, Martin RM, Neal DE; ProtecT Study Group.
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
N Engl J Med. 2016 Oct 13;375(15):1425-1437. Epub 2016 Sep 14.
Source | Full text | Similar articles



.

Hamdy FC, Donovan JL.
Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians.
JAMA. 2017 Mar 21;317(11):1121-1123. doi: 10.1001/jama.2017.1703.
Source | Full text | Similar articles



.

Jang JW, Drumm MR, Efstathiou JA, Paly JJ, Niemierko A, Ancukiewicz M, Talcott JA, Clark JA, Zietman AL.
Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.
Cancer Med. 2017 May 31. doi: 10.1002/cam4.1103. [Epub ahead of print]
Source | Full text | Similar articles



.

Johnson ME, Zaorsky NG, Martin JM, Ruth K, Greenberg RE, Uzzo RG, Hayes SB, Smaldone MC, Kutikov A, Viterbo R, Chen DY, Hallman MA, Sobczak ML, Horwitz EM.
Patient reported outcomes among treatment modalities for prostate cancer.
Can J Urol. 2016 Dec;23(6):8535-8545.
Source | Full text | Similar articles



.

Lardas M, Liew M, van den Bergh RC, De Santis M, Bellmunt J, Van den Broeck T, Cornford P, Cumberbatch MG, Fossati N, Gross T, Henry AM, Bolla M, Briers E, Joniau S, Lam TB, Mason MD, Mottet N, van der Poel HG, Rouvière O, Schoots IG, Wiegel T, Willemse PM, Yuan CY, Bourke L.
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
Eur Urol. 2017 Jul 27. pii: S0302-2838(17)30535-3. doi: 10.1016/j.eururo.2017.06.035. [Epub ahead of print]
Source | Full text | Similar articles



.

Mannas MP, Chedgy ECP, Black PC.
You Pays Your Money, You Takes Your Choice: Functional Outcomes Following Curative Treatment for Clinically Localized Prostate Cancer Commentary on: Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-reported Outcomes After 3 Years.
Urology. 2017 Jun 15. pii: S0090-4295(17)30625-8. doi: 10.1016/j.urology.2017.06.011. [Epub ahead of print]
Source | Full text | Similar articles



.

Penson DF.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Oct;198(4):744-745. doi: 10.1016/j.juro.2017.07.033. Epub 2017 Jul 18.
Source | Full text | Similar articles



.

Penson DF.
Quality of Life Outcomes Following Treatment for Localized Prostate Cancer: What's New and What's Not.
Eur Urol. 2017 Jul 20. pii: S0302-2838(17)30588-2. doi: 10.1016/j.eururo.2017.07.010. [Epub ahead of print]
Source | Full text | Similar articles



.

Pompe RS, Tian Z, Preisser F, Tennstedt P, Beyer B, Michl U, Graefen M, Huland H, Karakiewicz PI, Tilki D.
Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
Eur Urol Focus. 2017 Aug 28. pii: S2405-4569(17)30193-1. doi: 10.1016/j.euf.2017.08.001. [Epub ahead of print]
Source | Full text | Similar articles



.

Seftel AD.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Sep;198(3):466-468. doi: 10.1016/j.juro.2017.06.039. Epub 2017 Jun 20.
Source | Full text | Similar articles



.

Smith ZL, Eggener SE.
In localised prostate cancer, radical prostatectomy was associated with more sexual dysfunction and urinary incontinence than radiation or active surveillance.
Evid Based Med. 2017 Aug 16. pii: ebmed-2017-110772. doi: 10.1136/ebmed-2017-110772. [Epub ahead of print]
Comment on: Barochas DA et al. (2017), Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
Source | Full text | Similar articles



.

Taneja SS.
Re: Association between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes after 3 Years.
J Urol. 2017 Oct;198(4):743-744. doi: 10.1016/j.juro.2017.07.032. Epub 2017 Jul 18.
Source | Full text | Similar articles



.

Venkatesan P.
Quality of life after treatments for prostate cancer.
Lancet Oncol. 2017 Mar 30. pii: S1470-2045(17)30244-9. doi: 10.1016/S1470-2045(17)30244-9. [Epub ahead of print]
Source | Full text | Similar articles

RECOMMENDATIONS


.

Expert Panel on Urologic Imaging:, Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM.
ACR Appropriateness Criteria® Post-treatment Follow-up Prostate Cancer.
J Am Coll Radiol. 2018 May;15(5S):S132-S149. doi: 10.1016/j.jacr.2018.03.019.
Source | Full text | Similar articles



.

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M.
Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
J Sex Med. 2017 Mar;14(3):285-296. doi: 10.1016/j.jsxm.2016.11.325.
Source | Full text | Similar articles



.

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M.
Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
J Sex Med. 2017 Mar;14(3):297-315. doi: 10.1016/j.jsxm.2016.11.324.
Source | Full text | Similar articles



ANDROGEN DEPRIVATION THERAPY


.

Aksnessæther BY, Solberg A, Klepp OH, Myklebust TÅ, Skovlund E, Hoff SR, Vatten LJ, Lund JÅ.
Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?
Int J Radiat Oncol Biol Phys. 2018 Feb 5. pii: S0360-3016(18)30220-7. doi: 10.1016/j.ijrobp.2018.01.096. [Epub ahead of print]
Source | Full text | Similar articles



MONITORING VERSUS RADICAL PROSTATECTOMY


.

Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Etzioni R, Porter CR.
Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.
Cancer. 2015 Jul 15;121(14):2465-73. doi: 10.1002/cncr.29370. Epub 2015 Apr 6.
Source | Full text | Similar articles



.

Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, Aronson WJ, Brawer MK.
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.
N Engl J Med. 2017 Jul 13;377(2):132-142. doi: 10.1056/NEJMoa1615869.
Source | Full text | Similar articles



CARDIOVASCULAR EVENTS


.

Ahmad MN, Raghavan D.
Balancing Outcomes: Focusing on Value in Treatment of Prostate Cancer.
J Oncol Pract. 2018 Oct;14(10):588-590. doi: 10.1200/JOP.18.00523.
Source | Full text | Similar articles



.

Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM, Paszat LF.
Impact of androgen deprivation therapy on cardiovascular disease and diabetes.
J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923. Epub 2009 Jun 8.
Source | Full text | Similar articles



.

Dale W.
"Staging the aging" when considering androgen deprivation therapy for older men with prostate cancer.
J Clin Oncol. 2009 Jul 20;27(21):3420-2. doi: 10.1200/JCO.2009.22.9104. Epub 2009 Jun 8.
Editorial relating to: Alibhai SM et al, Impact of androgen deprivation therapy on cardiovascular disease and diabetes. [J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923]
Source | Full text | Similar articles



.

Gupta D, Lee Chuy K, Yang JC, Bates M, Lombardo M, Steingart RM.
Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer.
J Oncol Pract. 2018 Oct;14(10):580-587. doi: 10.1200/JOP.18.00178.
Source | Full text | Similar articles



.

Jin C, Fan Y, Meng Y, Shen C, Wang Y, Hu S, Cui C, Xu T, Yu W, Jin J.
A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients.
Prostate Cancer Prostatic Dis. 2016 Sep 6. doi: 10.1038/pcan.2016.35. [Epub ahead of print]
Source | Full text | Similar articles




Wallis CJ, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK.
Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.
Urology. 2016 Aug 5. pii: S0090-4295(16)30494-0. doi: 10.1016/j.urology.2016.08.002. [Epub ahead of print]
Source | Full text | Similar articles



CNS EVENTS


.

Pilon D, Behl AS, Ellis LA, Robitaille MN, Lefebvre P, Dawson NA.
Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy.
Am Health Drug Benefits. 2017 May;10(3):143-153.
Source | Full text | Similar articles

PARKINSON'S DESEASE


.

Abbate C, Caputo L, Damanti S, Zappa C, Nicolini P, Rossi PD, Arosio B, Mari D, De Riz MA, Dormia G, Trimarchi PD, Morello E, Monfardini S.
Reversible Parkinson's Dementia Associated with Withdrawal of Androgen-Deprivation Therapy for Prostate Cancer.
J Am Geriatr Soc. 2016 Aug 26. doi: 10.1111/jgs.14417. [Epub ahead of print]
Source | Full text | Similar articles



ALZHEIMER’S DISEASE


.

Nead KT, Sinha S, Nguyen PL.
Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis.
Prostate Cancer Prostatic Dis. 2017 Mar 28. doi: 10.1038/pcan.2017.10. [Epub ahead of print]
Source | Full text | Similar articles



DEPRESSION


.

Cheng Y, Gao XH, Li XJ, Cao QH, Zhao DD, Zhou JR, Wu HX, Wang Y, You LJ, Yang HB, He YL, Li YR, Bian JS, Zhu QY, Birnbaumer L, Yang Y.
Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.
Oncogene. 2018 Mar 8. doi: 10.1038/s41388-018-0177-4. [Epub ahead of print]
Source | Full text | Similar articles



FUNCTIONAL OUTCOMES


.

Capogrosso P, Ventimiglia E, Cazzaniga W, Stabile A, Pederzoli F, Boeri L, Gandaglia G, Dehò F, Briganti A, Montorsi F, Salonia A.
Long-term penile morphometric alterations in patients treated with robot-assisted versus open radical prostatectomy.
Andrology. 2017 Dec 1. doi: 10.1111/andr.12446. [Epub ahead of print]
Source | Full text | Similar articles



.

Chung E, Brock G.
Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors.
J Sex Med. 2013 Feb;10 Suppl 1:102-11. doi: 10.1111/j.1743-6109.2012.03005.x. Epub 2013 Feb 6.
Source | Full text | Similar articles



.

Ellison JS, He C, Wood DP.
Early Post-Operative Urinary and Sexual Function Predicts Functional Recovery at One Year Following Prostatectomy.
J Urol. 2013 Apr 19. doi:pii: S0022-5347(13)04095-0. 10.1016/j.juro.2013.04.045. [Epub ahead of print]
Source | Full text | Similar articles



.

Gilbert SM, Dunn RL, Miller DC, Montgomery JS, Skolarus TA, Weizer AZ, Wood DP Jr, Hollenbeck BK.
Functional Outcomes Following Nerve-Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve-Sparing Prostatectomy: Results from a Randomized Controlled Trial.
J Urol. 2017 Apr 6. pii: S0022-5347(17)45409-7. doi: 10.1016/j.juro.2017.03.133. [Epub ahead of print]
Source | Full text | Similar articles



.

Kimura M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, Donatucci CF, Moul JW.
Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.
Andrology. 2013 Mar;1(2):256-61. doi: 10.1111/j.2047-2927.2012.00036.x. Epub 2012 Nov 29.
Source | Full text | Similar articles



.

Tyson MD 2nd, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hashibe M, Paddock LE, Stroup A, Chen V, Conwill R, McCollum D, Penson DF, Barocas DA.
Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
Eur Urol. 2018 Feb 28. pii: S0302-2838(18)30119-2. doi: 10.1016/j.eururo.2018.02.012. [Epub ahead of print]
Source | Full text | Similar articles



.

van Stam MA, van der Poel H.
The New Standard: Personalised Information about the Risks and Benefits of Treatment Strategies for Localised Prostate Cancer.
Eur Urol. 2018 Apr 13. pii: S0302-2838(18)30199-4. doi: 10.1016/j.eururo.2018.03.018. [Epub ahead of print]
Comment on: Tyson MD 2nd et al., Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol. 2018 Feb 28.
Source | Full text | Similar articles



COMPARE LONG-TERM URINARY, BOWEL, AND SEXUAL FUNCTION AFTER RP OR EBRT


*

Razzak M.
Urological cancer: Life after prostate cancer treatment.
Nat Rev Clin Oncol. 2013 Mar;10(3):123. doi: 10.1038/nrclinonc.2013.21. Epub 2013 Feb 12.

Comment relating to: Resnick MJ et al, Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
Source | Full text | Similar articles



.

Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF.
Long-term functional outcomes after treatment for localized prostate cancer.
N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
Source | Full text | Similar articles



.

Rocco B et al.
(Correspondence) Functional Outcomes after Treatment for Prostate Cancer
N Engl J Med. 2013 Apr 25; 368:1653-1654. DOI: 10.1056/NEJMc1302509
Refers to: Resnick MJ et al, Long-term functional outcomes after treatment for localized prostate cancer. [N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.]
Source | Full text



COMPARE LAPAROSCOPIC VERSUS OPEN RP


.

Barry MJ, Gallagher PM, Skinner JS, Fowler FJ Jr.
Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men.
J Clin Oncol. 2012 Feb 10;30(5):513-8. doi: 10.1200/JCO.2011.36.8621. Epub 2012 Jan 3.
Source | Full text | Similar articles



.

Springer C, Inferrera A, Pini G, Mohammed N, Fornara P, Greco F.
Laparoscopic versus open bilateral intrafascial nerve-sparing radical prostatectomy after TUR-P for incidental prostate cancer: surgical outcomes and effect on postoperative urinary continence and sexual potency.
World J Urol. 2013 Feb 12. [Epub ahead of print]
Source | Full text | Similar articles



PARTIAL GLAND ABLATION WITH HIGH INTENSITY FOCUSED ULTRASOUND


.

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L, Klotz L.
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer.
J Urol. 2019 Jan;201(1):113-119. doi: 10.1016/j.juro.2018.07.040.
Source | Full text | Similar articles



ERECTILE DYSFUNCTION


.

Basal S, Wambi C, Acikel C, Gupta M, Badani K.
Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
BJU Int. 2013 Apr;111(4):658-65. doi: 10.1111/j.1464-410X.2012.11487.x. Epub 2012 Nov 27.
Source | Full text | Similar articles



.

Brock G, Montorsi F, Büttner H, Henneges C, Mulhall J.
Reply from authors re: Arthur L. Burnett. Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy. Eur Urol 2014;65:597-8: although erection rehabilitation after prostatectomy remains indefinite, the most effective treatment, the earliest recovery, and the preservation of erectile function remain a definite goal.
Eur Urol. 2014 Mar;65(3):598-9. doi: 10.1016/j.eururo.2013.11.015. Epub 2013 Nov 19.
Source | Full text | Similar articles



.

Burnett AL.
Erection rehabilitation after radical prostatectomy: definite purpose, indefinite strategy.
Eur Urol. 2014 Mar;65(3):597-8. doi: 10.1016/j.eururo.2013.10.018. Epub 2013 Oct 28.
Source | Full text | Similar articles



.

Capogrosso P, Vertosick EA, Benfante NE, Eastham JA, Scardino PJ, Vickers AJ, Mulhall JP.
Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade.
Eur Urol. 2018 Sep 17. pii: S0302-2838(18)30641-9. doi: 10.1016/j.eururo.2018.08.039. [Epub ahead of print]
Source | Full text | Similar articles



.

Carter S, Le JD, Hu JC.
Anatomic and technical considerations for optimizing recovery of sexual function during robotic-assisted radical prostatectomy.
Curr Opin Urol. 2013 Jan;23(1):88-94. doi: 10.1097/MOU.0b013e32835b6602.
Source | Full text | Similar articles



.

Fan Y.
[Tadalafil rehabilitation therapy for erectile dysfunction following prostatectomy].
Zhonghua Nan Ke Xue. 2012 Oct;18(10):953-6. Chinese.
Source | Abstract | Similar articles



.

Fode M, Serefoglu EC, Albersen M, Sønksen J.
Sexuality Following Radical Prostatectomy: Is Restoration of Erectile Function Enough?
Sex Med Rev. 2016 Aug 24. pii: S2050-0521(16)30031-2. doi: 10.1016/j.sxmr.2016.07.005. [Epub ahead of print]
Source | Full text | Similar articles



.

Gallina A, Ferrari M, Suardi N, Capitanio U, Abdollah F, Tutolo M, Bianchi M, Saccà A, Salonia A, Rigatti P, Montorsi F, Briganti A.
Erectile function outcome after bilateral nerve sparing radical prostatectomy: which patients may be left untreated?
J Sex Med. 2012 Mar;9(3):903-8. doi: 10.1111/j.1743-6109.2011.02622.x. Epub 2012 Jan 12.
Source | Full text | Similar articles



.*

Hong SK, Han BK, Jeong SJ, Byun SS, Lee SE.
Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy.
J Urol. 2007 Aug;178(2):613-6. Epub 2007 Jun 13.
Source | Full text | Similar articles



.

Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H.
Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Eur Urol. 2014 Mar;65(3):587-96. doi: 10.1016/j.eururo.2013.09.051. Epub 2013 Oct 13.
Source | Full text | Similar articles



.

Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ.
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
BJU Int. 2013 Oct;112(6):844-51. doi: 10.1111/bju.12253. Epub 2013 Aug 13.
Source | Full text | Similar articles



.

Philippou YA, Jung JH, Steggall MJ, O'Driscoll ST, Bakker CJ, Bodie JA, Dahm P.
Penile rehabilitation for postprostatectomy erectile dysfunction.
Cochrane Database Syst Rev. 2018 Oct 23;10:CD012414. doi: 10.1002/14651858.CD012414.pub2.
Source | Full text | Similar articles



.

Storås AH, Sanda MG, Boronat OG, Chang P, Patil D, Crociani C, Suarez JF, Cvancarova M, Loge JH, Fosså SD.
Erectile Dysfunction and Sexual Problems Two to Three Years After Prostatectomy Among American, Norwegian, and Spanish Patients.
Clin Genitourin Cancer. 2015 Oct 26. pii: S1558-7673(15)00265-7. doi: 10.1016/j.clgc.2015.10.009. [Epub ahead of print]
Source | Full text | Similar articles



Sildenafil


.

Ilic D, Hindson B, Duchesne G, Millar JL.
A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer.
J Med Imaging Radiat Oncol. 2013 Feb;57(1):81-8. doi: 10.1111/j.1754-9485.2012.02461.x. Epub 2012 Oct 18.
Source | Full text | Similar articles



EARLY VS DELAYED USE OF SILDENAFIL


.

Jo JK, Jeong SJ, Oh JJ, Lee SW, Lee S, Hong SK, Byun SS, Lee SE.
Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: a prospective randomized trial.
J Urol. 2018 Jan 4. pii: S0022-5347(18)30009-0. doi: 10.1016/j.juro.2017.12.060. [Epub ahead of print]
Source | Abstract | Similar articles



USE OF PDE-5 INHIBITORS AND BIOCHEMICAL RECURRENCE


.

Bora GS, Gupta VG, Mavuduru RS.
Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
J Urol. 2016 Mar;195(3):804; discussion 804-5. doi: 10.1016/j.juro.2015.08.103. Epub 2015 Nov 25
Source | Full text | Similar articles



.

Fode M, Østergren PB, Jensen CFS, Jakobsen H, Sønksen J.
Treatment effects of phosphodiesterase-5 inhibitors may improve with time following nerve-sparing radical prostatectomy.
Scand J Urol. 2017 Oct 23:1-3. doi: 10.1080/21681805.2017.1387603. [Epub ahead of print]
Source | Full text | Similar articles



.*

Gallina A, Bianchi M, Gandaglia G, Cucchiara V, Suardi N, Montorsi F, Briganti A.
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy.
Eur Urol. 2015 Nov;68(5):750-3. doi: 10.1016/j.eururo.2015.02.002. Epub 2015 Feb 17.
Source | Full text | Similar articles



.

Hofer L, Radtke JP, Rapp C, Pahernik S, Teber D, Hohenfellner M, Hadaschik B.
[Recurrence-free survival after radical prostatectomy and PDE-5 inhibitor intake].
Urologe A. 2016 Nov 10. [Epub ahead of print] German.
Source | Full text | Similar articles



.*

Jo JK, Kim K, Lee SE, Lee JK, Byun SS, Hong SK.
Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence.
Ann Surg Oncol. 2016 May;23(5):1760-7. doi: 10.1245/s10434-015-5059-1. Epub 2015 Dec 30.
Source | Full text | Similar articles



.

Kim SJ, Kim JH, Chang HK, Kim KH.
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy.
J Exerc Rehabil. 2016 Jun 30;12(3):143-7. doi: 10.12965/jer.1632646.323.
Source | Full text | Similar articles



.

Loeb S, Folkvaljon Y, Robinson D, Schlomm T, Garmo H, Stattin P.
Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.
Eur Urol. 2016 Nov;70(5):824-828. doi: 10.1016/j.eururo.2015.12.013. Epub 2015 Dec 29.
Source | Full text | Similar articles



.

Loeb S, Schlomm T, Stattin P.
Associations Do Not Equal Causation: Clinical Relevance of Statistical Associations of Phosphodiesterase Type 5 Inhibitors with Prostate Cancer Progression and Melanoma.
Eur Urol. 2015 Nov;68(5):754-5. doi: 10.1016/j.eururo.2015.07.023. Epub 2015 Jul 31.
Source | Full text | Similar articles



.

Machen GL, Rajab MH, Pruszynski J, Coffield KS.
Phosphodiesterase type 5 inhibitors usage and prostate cancer: a match-paired analysis.
Transl Androl Urol. 2017 Oct;6(5):879-882. doi: 10.21037/tau.2017.06.02.
Source | Full text | Similar articles



.

Michl U, Molfenter F, Graefen M, Tennstedt P, Ahyai S, Beyer B, Budäus L, Haese A, Heinzer H, Oh SJ, Salomon G, Schlomm T, Steuber T, Thederan I, Huland H, Tilki D.
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy.
J Urol. 2015 Feb;193(2):479-83. doi: 10.1016/j.juro.2014.08.111. Epub 2014 Sep 6
Source | Full text | Similar articles



.

Vehmas T.
Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
J Urol. 2015 Aug;194(2):595-6. doi: 10.1016/j.juro.2015.01.116. Epub 2015 May 5.
Source | Full text | Similar articles



.

Wu Y, Qu X, Wang Y, Xia J, Gu Y, Qian Q, Hong Y.
Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis.
Andrologia. 2018 Nov 16:e13198. doi: 10.1111/and.13198. [Epub ahead of print]
Source | Full text | Similar articles



.

Yafi FA, Sharlip ID, Becher EF.
Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction.
Sex Med Rev. 2017 Sep 8. pii: S2050-0521(17)30095-1. doi: 10.1016/j.sxmr.2017.08.001. [Epub ahead of print]
Source | Full text | Similar articles



ANEJACULATION


.

Sullivan JF, Stember DS, Deveci S, Akin-Olugbade Y, Mulhall JP.
Ejaculation profiles of men following radiation therapy for prostate cancer.
J Sex Med. 2013 May;10(5):1410-6. doi: 10.1111/jsm.12101. Epub 2013 Feb 22.
Source | Full text | Similar articles



NOCTURIA


.

Hur KJ, Lee KW, Kim SJ, Kim KS, Bae WJ, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW.
Changes in Nocturia and Lower Urinary Tract Symptoms after Radical Prostatectomy.
World J Mens Health. 2015 Dec;33(3):194-201. doi: 10.5534/wjmh.2015.33.3.194. Epub 2015 Dec 23.
Source | Full text | Similar articles



ORGASMIC DYSFUNCTION


.

Clavell-Hernández J, Martin C, Wang R.
Orgasmic Dysfunction Following Radical Prostatectomy: Review of Current Literature.
Sex Med Rev. 2017 Nov 3. pii: S2050-0521(17)30120-8. doi: 10.1016/j.sxmr.2017.09.003. [Epub ahead of print]
Source | Full text | Similar articles



REDUCED PENILE SIZE


.

Parekh A, Chen MH, Hoffman KE, Choueiri TK, Hu JC, Bennett CL, Kattan MW, Sartor O, Stein K, Graham PL, D'Amico AV, Nguyen PL.
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
Urology. 2013 Jan;81(1):130-4. doi: 10.1016/j.urology.2012.08.068.
Source | Full text | Similar articles



SEXUAL LIFE


.

Sato Y, Tanda H, Nakajima H, Nitta T, Akagashi K, Hanzawa T, Tobe M, Haga K, Uchida K, Honma I.
Dissociation between patients and their partners in expectations for sexual life after radical prostatectomy.
Int J Urol. 2013 Mar;20(3):322-8. doi: 10.1111/iju.12022. Epub 2013 Jan 8.
Source | Full text | Similar articles



URINARY INCONTINENCE




Radical prostatectomy


.

Capogrosso P, Sanchez-Salas R, Salonia A, Cathala N, Mombet A, Sivaraman A, Barret E, Montorsi F, Cathelineau X.
Recovery of urinary continence after radical prostatectomy.
Expert Rev Anticancer Ther. 2016 Oct;16(10):1039-52. doi: 10.1080/14737140.2016.1233818. Epub 2016 Sep 21.
Source | Full text | Similar articles



.

Chen YC, Lin PH, Jou YY, Lin VC.
Surgical treatment for urinary incontinence after prostatectomy: A meta-analysis and systematic review.
PLoS One. 2017 May 3;12(5):e0130867. doi: 10.1371/journal.pone.0130867. eCollection 2017.
Source | Full text | Similar articles



.

Gacci M.
Editorial comment to postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.
Int J Urol. 2013 Apr;20(4):419-20. doi: 10.1111/j.1442-2042.2012.03163.x. Epub 2012 Sep 12.
Source | Full text | Similar articles



.

Gandaglia G, Albersen M, Suardi N, Gallina A, Abdollah F, Castiglione F, Capitanio U, Salonia A, Rigatti P, Hedlund P, Montorsi F, Briganti A.
Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.
Int J Urol. 2013 Apr;20(4):413-9. doi: 10.1111/j.1442-2042.2012.03149.x. Epub 2012 Sep 12.
Source | Full text | Similar articles



.

Tilki D, Preisser F, Karakiewicz P, Shariat SF, Graefen M, Huland H, Chun FK, Pompe RS.
The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy.
World J Urol. 2018 Mar 26. doi: 10.1007/s00345-018-2274-y. [Epub ahead of print]
Source | Full text | Similar articles



Salvage radiotherapy


.

Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Kempel MM, Meidahl Petersen P, Borre M.
Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer
Scand J Urol. 2017 Jul 27:1-7. doi: 10.1080/21681805.2017.1354314. [Epub ahead of print]
Source | Full text | Similar articles



.

Nyarangi-Dix JN, Steimer J, Bruckner T, Jakobi H, Koerber SA, Hadaschik B, Debus J, Hohenfellner M.
Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
World J Urol. 2017 Aug 31. doi: 10.1007/s00345-017-2081-x. [Epub ahead of print]
Source | Full text | Similar articles



MEASUREMENT OF METASTASIS IN THE FOLLOW-UP


.

Xie W, Regan MM, Sweeney CJ.
Reply to Y. Zhu et al
J Clin Oncol. 2017 Dec DOI: 10.1200/JCO.2017.76.2872
Source | Abstract | Similar articles




Zhu Y, Ye D.
Measurement of Metastasis in the Follow-Up of Localized Prostate Cancer.
J Clin Oncol. 2017 Dec 21:JCO2017762005. doi: 10.1200/JCO.2017.76.2005. [Epub ahead of print]
Source | Abstract | Similar articles



OSTEOPOROSIS AND FRACTURE RISK


.

Grey A.
Osteoporosis and Fracture Risk in Men with Prostate Cancer.
Eur Urol. 2016 Jun;69(6):1026-7. doi: 10.1016/j.eururo.2015.12.036. Epub 2015 Dec 31.
Source | Full text | Similar articles



.

Langley RE, Kynaston HG, Alhasso AA, Duong T, Paez EM, Jovic G, Scrase CD, Robertson A, Cafferty F, Welland A, Carpenter R, Honeyfield L, Abel RL, Stone M, Parmar MK, Abel PD.
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Eur Urol. 2015 Dec 17. pii: S0302-2838(15)01201-4. doi: 10.1016/j.eururo.2015.11.030. [Epub ahead of print]
Source | Full text | Similar articles



.

Varsavsky M, Romero Muñoz M, Ávila Rubio V, Becerra A, García Martín A, Martínez Díaz-Guerra G, Rozas Moreno P, Jódar Gimeno E, Muñoz Torres M.
Consensus document on osteoporosis in males.
Endocrinol Diabetes Nutr. 2018 Mar 9. pii: S2530-0164(18)30011-9. doi: 10.1016/j.endinu.2017.12.005. [Epub ahead of print] English, Spanish.
Source | Full text | Similar articles



.

Wallis CJ, Mahar AL, Satkunasivam R, Herschorn S, Kodama RT, Lee Y, Kulkarni GS, Narod SA, Nam RK.
Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.
Urology. 2016 Aug 5. pii: S0090-4295(16)30494-0. doi: 10.1016/j.urology.2016.08.002. [Epub ahead of print]
Source | Full text | Similar articles



QUALITY OF LIFE


.

Jakobsson L, Persson L, Lundqvist P.
Daily life and life quality 3 years following prostate cancer treatment.
BMC Nurs. 2013 Apr 10;12:11. doi: 10.1186/1472-6955-12-11.
Source | Full text | Similar articles



.

Zelefsky MJ, Poon BY, Eastham J, Vickers A, Pei X, Scardino PT.
Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.
Radiother Oncol. 2016 Jan 9. pii: S0167-8140(15)00668-4. doi: 10.1016/j.radonc.2015.11.035. [Epub ahead of print]
Source | Full text | Similar articles



SURGERY TYPE AND DEGREE OF NERVE SPARING


.

Strassberg DS, Zavodni SM, Gardner P, Dechet C, Stephenson RA, Sewell KK.
Quality of Life Following Prostatectomy as a Function of Surgery Type and Degree of Nerve Sparing.
Curr Urol. 2017 Nov;11(1):16-20. doi: 10.1159/000447189. Epub 2017 Nov 30.
Source | Full text | Similar articles



SURGERY VS BRACHYTHERAPY


.

Crook JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett M, Fleshner N.
Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.
J Clin Oncol. 2011 Feb 1;29(4):362-8. doi: 10.1200/JCO.2010.31.7305. Epub 2010 Dec 13.
Source | Full text | Similar articles



ADVANCED(T3N0M0) PROSTATE CARCINOMA


.

Moinpour CM, Hayden KA, Unger JM, Thompson IM Jr, Redman MW, Canby-Hagino ED, Higgins BA, Sullivan JW, Lemmon D, Breslin S, Crawford ED, Southwest Oncology Group.
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
J Clin Oncol. 2008 Jan 1;26(1):112-20. doi: 10.1200/JCO.2006.10.4505.
Source | Full text | Similar articles



SURGERY VS BRACHYTHERAPY OR EXTERNAL RADIOTHERAPY


.

Chen RC, Clark JA, Talcott JA.
Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
J Clin Oncol. 2009 Aug 20;27(24):3916-22. doi: 10.1200/JCO.2008.18.6486. Epub 2009 Jul 20.
Source | Full text | Similar articles



.

Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M.
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4.
Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779.
Source | Full text | Erratum | Similar articles



SIDE EFFECTS OF RADIOTHERAPY


.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30722-X. doi: 10.1016/j.eururo.2018.09.034. [Epub ahead of print]
Source | Full text | Similar articles



LOCAL-ONLY OR LOCAL-PLUS-PELVIC RADIOTHERAPY


.

Waldstein C, Dörr W, Pötter R, Widder J, Goldner G.
Postoperative radiotherapy for prostate cancer : Morbidity of local-only or local-plus-pelvic radiotherapy.
Strahlenther Onkol. 2017 Sep 19. doi: 10.1007/s00066-017-1215-9. [Epub ahead of print]
Source | Full text | Similar articles



RT-RELATED RECTAL TOXICITY


.*

Palumbo I, Matrone F, Montesi G, Bellavita R, Lupattelli M, Saldi S, Frattegiani A, Arena E, Mariucci C, Falcinelli L, Bini V, Aristei C.
Statins Protect Against Acute RT-related Rectal Toxicity in Patients with Prostate Cancer: An Observational Prospective Study.
Anticancer Res. 2017 Mar;37(3):1453-1457.
Source | Full text | Similar articles



QOL AFTER SALVAGE RADIOTHERAPY


.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Plasswilm L, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Kaouthar K, Wust P, Thalmann GN, Aebersold DM.
Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
J Clin Oncol. 2015 Dec 10;33(35):4158-66. doi: 10.1200/JCO.2015.63.3529. Epub 2015 Nov 2.

Source | Full text | Similar articles



.

van Dessel LF, Reuvers SHM, Bangma CH, Aluwini S.
Salvage radiotherapy after radical prostatectomy: Long-term results of urinary incontinence, toxicity and treatment outcomes.
Clin Transl Radiat Oncol. 2018 May 29;11:26-32. doi: 10.1016/j.ctro.2018.05.001. eCollection 2018 Jun.
Source | Full text | Similar articles



QOL AFTER SURGERY AND SALVAGE RADIOTHERAPY


.

Ervandian M, Høyer M, Petersen SE, Sengeløv L, Hansen S, Kempel MM, Meidahl Petersen P, Borre M.
Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer
Scand J Urol. 2017 Jul 27:1-7. doi: 10.1080/21681805.2017.1354314. [Epub ahead of print]
Source | Full text | Similar articles



POSTOPERATIVE VS SALVAGE RADIOTHERAPY


.

Vogel MME, Kessel KA, Gschwend JE, Weichert W, Wilkens JJ, Combs SE.
Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
Strahlenther Onkol. 2018 Sep 4. doi: 10.1007/s00066-018-1359-2. [Epub ahead of print]
Source | Full text | Similar articles



SECONDARY CANCER


.

Okajima K, Ishikawa K, Matsuura T, Tatebe H, Fujiwara K, Hiroi K, Hasegawa H, Nishimura Y.
Multiple primary malignancies in patients with prostate cancer: increased risk of secondary malignancies after radiotherapy.
Int J Clin Oncol. 2012 Nov 20. [Epub ahead of print]
Source | Full text | Similar articles



Secondary bladder cancer


.

Fiorentino A, Errico A, Scarcia M.
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.09.034: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial.
Eur Urol. 2018 Nov 27. pii: S0302-2838(18)30881-9. doi: 10.1016/j.eururo.2018.11.024. [Epub ahead of print]
Letter to the Editor relating to: Moschini M et al, Eur Urol. 2018 Nov 29. pii: S0302-2838(18)30941-2. doi: 10.1016/j.eururo.2018.11.042. [Epub ahead of print]
Source | Full text | Similar articles



.

Moschini M, Zaffuto E, Mattei A, Karakiewicz PI, Shariat SF.
Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.09.034.: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial.
Eur Urol. 2018 Nov 30. pii: S0302-2838(18)30942-4. doi: 10.1016/j.eururo.2018.11.043. [Epub ahead of print]
Letter to the Editor relating to: Fiorentino A et al, Eur Urol. 2018 Nov 27. pii: S0302-2838(18)30881-9. doi: 10.1016/j.eururo.2018.11.024. [Epub ahead of print]
Source | Full text | Similar articles



.

Moschini M, Zaffuto E, Mattei A, Karakiewicz PI, Shariat SF.
Reply to Nicholas G. Zaorsky, Daniel E. Spratt, and Pierre Blanchard's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.09.034.
Eur Urol. 2018 Nov 29. pii: S0302-2838(18)30941-2. doi: 10.1016/j.eururo.2018.11.042. [Epub ahead of print]
Letter to the Editor relating to: Zaorsky NG, Eur Urol. 2018 Nov 22. pii: S0302-2838(18)30882-0. doi: 10.1016/j.eururo.2018.11.025. [Epub ahead of print]
Source | Full text | Similar articles



.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.
External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Eur Urol. 2018 Oct 4. pii: S0302-2838(18)30722-X. doi: 10.1016/j.eururo.2018.09.034. [Epub ahead of print]
Source | Full text | Similar articles



.

Zaorsky NG, Spratt DE, Blanchard P.
Re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.09.034.
Eur Urol. 2018 Nov 22. pii: S0302-2838(18)30882-0. doi: 10.1016/j.eururo.2018.11.025. [Epub ahead of print]
Letter to the Editor relating to: Moschini M et al, Eur Urol. 2018 Nov 29. pii: S0302-2838(18)30941-2. doi: 10.1016/j.eururo.2018.11.042. [Epub ahead of print]
Source | Full text | Similar articles



THERANOSTICS


.

van Kalmthout L, Stam A, Gans R, Lam M.
Visual deficit possibly caused by lutetium-177 PSMA treatment.
BMJ Case Rep. 2018 Oct 8;2018. pii: bcr-2018-225508. doi: 10.1136/bcr-2018-225508.
Source | Abstract | Similar articles



TREATMENT OF BENIGN ENLARGEMENT OF THE PROSTATE


.

Wallerstedt A, Strom P, Gronberg H, Nordstrom T, Eklund M.
Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036. Epub 2018 Mar 14.
Source | Full text | Similar articles



.

Walsh PC.
RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study.
J Natl Cancer Inst. 2018 Oct 30. doi: 10.1093/jnci/djy186. [Epub ahead of print]
Correspondence relating to: Wallerstedt A et al, Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective Study. J Natl Cancer Inst. 2018 Nov 1;110(11):1216-1221. doi: 10.1093/jnci/djy036. Epub 2018 Mar 14.
Source | Full text | Similar articles



SYMPTOM BURDEN


.

Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA, Darwish-Yassine M, Skolarus TA.
Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care.
BJU Int. 2016 Sep;118(3):372-8. doi: 10.1111/bju.13329. Epub 2015 Oct 26.
Source | Full text | Similar articles



.

Johnson MH.
Tailored prostate cancer survivorship: one size does not fit all.
BJU Int. 2016 Sep;118(3):343-4. doi: 10.1111/bju.13363. Epub 2016 Aug 14
Source | Full text | Similar articles



SUPRA-PUBIC VERSUS URETHRAL CATHETER


.

Bertolo R, Tracey A, Dasgupta P, Rocco B, Micali S, Bianchi G, Hampton L, Tewari AK, Porpiglia F, Autorino R.
Supra-pubic versus urethral catheter after robot-assisted radical prostatectomy: systematic review of current evidence.
World J Urol. 2018 Mar 29. doi: 10.1007/s00345-018-2275-x. [Epub ahead of print]
Source | Full text | Similar articles